Our Mission
Our goal is to develop collaborative, impactful research that will lead to improved brain health for the people of Cleveland, and for all.
NervGen to pursue Clinical Trial
Dr. Jerry Silver's NVG-291 will be used in a clinical trial on spinal cord injury to be performed at Shirley Ryan AbilityLab.
The Latest
Did you miss our Annual Meeting in August? Watch videos of lectures from David Standaert MD PhD, Aasef Shaikh MD PhD & Cathe Schwartz MPA, Andrew Pieper MD PhD, and Christopher Walsh MD PhD.